PubRank
Search
About
Gabor G Illei
Author PubWeight™ 55.80
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Identification and characterization of circulating human transitional B cells.
Blood
2005
3.62
2
Basophils and the T helper 2 environment can promote the development of lupus nephritis.
Nat Med
2010
3.24
3
The majority of microRNAs detectable in serum and saliva is concentrated in exosomes.
PLoS One
2012
3.14
4
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
Arthritis Rheum
2003
2.11
5
Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
Transfusion
2003
2.05
6
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.
J Am Soc Nephrol
2009
2.03
7
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Arthritis Rheum
2006
1.87
8
Urinary exosomal transcription factors, a new class of biomarkers for renal disease.
Kidney Int
2008
1.86
9
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures.
Blood
2009
1.83
10
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome.
Nat Genet
2013
1.79
11
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
J Clin Invest
2003
1.63
12
MicroRNAs as biomarkers in rheumatic diseases.
Nat Rev Rheumatol
2010
1.59
13
miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1.
J Am Soc Nephrol
2013
1.57
14
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction.
Proc Natl Acad Sci U S A
2012
1.38
15
Pathogenesis of Sjögren's syndrome.
Curr Opin Rheumatol
2009
1.38
16
MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome.
Arthritis Rheum
2011
1.31
17
Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome.
Autoimmunity
2009
1.31
18
Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis.
Immunity
2012
1.30
19
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
Arthritis Rheum
2004
1.25
20
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.
Blood
2004
1.23
21
Cytokines in Sjogren's syndrome: potential therapeutic targets.
Ann Rheum Dis
2010
1.15
22
Development of a gene transfer-based treatment for radiation-induced salivary hypofunction.
Oral Oncol
2009
1.15
23
Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
Ann Rheum Dis
2012
1.10
24
Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland.
J Gene Med
2010
1.09
25
Abnormal differentiation of memory T cells in systemic lupus erythematosus.
Arthritis Rheum
2006
1.06
26
Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction.
Biochim Biophys Acta
2005
0.99
27
Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction.
Handb Exp Pharmacol
2009
0.96
28
MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease.
Autoimmun Rev
2010
0.94
29
Effect of serotype 5 adenoviral and serotype 2 adeno- associated viral vector-mediated gene transfer to salivary glands on the composition of saliva.
Hum Gene Ther
2006
0.87
30
A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.
Arthritis Rheum
2004
0.83
31
Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
J Rheumatol
2002
0.82
32
Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent.
PLoS One
2011
0.82
33
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus.
Endocr Metab Immune Disord Drug Targets
2009
0.81
34
Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.
Arthritis Rheum
2013
0.80
35
Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus.
Nat Clin Pract Rheumatol
2006
0.78
36
Monocyte response to Th1 stimulation and effector function toward human mesangial cells are not impaired in patients with lupus nephritis.
Clin Immunol
2003
0.78
37
Adrenomedullary response to glucagon in patients with primary Sjögren's syndrome.
Cell Mol Neurobiol
2012
0.78
38
Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögren's Syndrome.
Arthritis Rheumatol
2015
0.77
39
The role of immune ablation and stem cell transplantation in severe SLE.
Best Pract Res Clin Rheumatol
2005
0.77
40
The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland.
Rheumatology (Oxford)
2012
0.77
41
Hematopoietic stem cell transplantation in autoimmune diseases: is the glass half full or half empty?
Arthritis Rheum
2006
0.76
42
Can quantified salivary gland scintigraphy results aid diagnosis of patients with sicca symptoms?
Nat Clin Pract Rheumatol
2008
0.75